Bharat Biotech's US partner Ocugen seeks FDA approval for Covaxin use for children below 18…
WorldTags: COVID19coronavirusSri LankaThe approval request by Ocugen is based on result of Phase 2/3 pediatric clinical trial conducted by Bharat Biotech in India with 526 children in the age group 2-18 years.
Ocugen Inc., Bharat…
